BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 31958633)

  • 1. VDR in salivary gland homeostasis and cancer.
    DeSantis KA; Robilotto SL; Matson M; Kotb NM; Lapierre CM; Minhas Z; Leder AA; Abdul K; Facteau EM; Welsh J
    J Steroid Biochem Mol Biol; 2020 May; 199():105600. PubMed ID: 31958633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammary adipocytes bioactivate 25-hydroxyvitamin D₃ and signal via vitamin D₃ receptor, modulating mammary epithelial cell growth.
    Ching S; Kashinkunti S; Niehaus MD; Zinser GM
    J Cell Biochem; 2011 Nov; 112(11):3393-405. PubMed ID: 21769914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Function of the vitamin D endocrine system in mammary gland and breast cancer.
    Welsh J
    Mol Cell Endocrinol; 2017 Sep; 453():88-95. PubMed ID: 28579119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of mammary tumor cell lines from wild type and vitamin D3 receptor knockout mice.
    Zinser GM; McEleney K; Welsh J
    Mol Cell Endocrinol; 2003 Feb; 200(1-2):67-80. PubMed ID: 12644300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to 1,25D-induced differentiation in human acute myeloid leukemia HL60-40AF cells is associated with reduced transcriptional activity and nuclear localization of the vitamin D receptor.
    Garay E; Donnelly R; Wang X; Studzinski GP
    J Cell Physiol; 2007 Dec; 213(3):816-25. PubMed ID: 17520689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diverse Regulation of Vitamin D Receptor Gene Expression by 1,25-Dihydroxyvitamin D and ATRA in Murine and Human Blood Cells at Early Stages of Their Differentiation.
    Janik S; Nowak U; Łaszkiewicz A; Satyr A; Majkowski M; Marchwicka A; Śnieżewski Ł; Berkowska K; Gabryś M; Cebrat M; Marcinkowska E
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28635660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stable expression of human VDR in murine VDR-null cells recapitulates vitamin D mediated anti-cancer signaling.
    Keith ME; LaPorta E; Welsh J
    Mol Carcinog; 2014 Apr; 53(4):286-99. PubMed ID: 23681781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Actions of 1,25(OH)2-vitamin D3 on the cellular cycle depend on VDR and p38 MAPK in skeletal muscle cells.
    Irazoqui AP; Boland RL; Buitrago CG
    J Mol Endocrinol; 2014 Dec; 53(3):331-43. PubMed ID: 25316911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prostate cancer TMPRSS2:ERG fusion synergizes with the vitamin D receptor (VDR) to induce CYP24A1 expression-limiting VDR signaling.
    Kim JS; Roberts JM; Bingman WE; Shao L; Wang J; Ittmann MM; Weigel NL
    Endocrinology; 2014 Sep; 155(9):3262-73. PubMed ID: 24926821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptomic Response to 1,25-Dihydroxyvitamin D in Human Fibroblasts with or without a Functional Vitamin D Receptor (VDR): Novel Target Genes and Insights into VDR Basal Transcriptional Activity.
    Costa PLF; França MM; Katayama ML; Carneiro ET; Martin RM; Folgueira MAK; Latronico AC; Ferraz-de-Souza B
    Cells; 2019 Apr; 8(4):. PubMed ID: 30959822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
    J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SIRT1 enzymatically potentiates 1,25-dihydroxyvitamin D
    Sabir MS; Khan Z; Hu C; Galligan MA; Dussik CM; Mallick S; Stone AD; Batie SF; Jacobs ET; Whitfield GK; Haussler MR; Heck MC; Jurutka PW
    J Steroid Biochem Mol Biol; 2017 Sep; 172():117-129. PubMed ID: 28636886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Squamous/epidermoid differentiation in normal breast and salivary gland tissues and their corresponding tumors originate from p63/K5/14-positive progenitor cells.
    Boecker W; Stenman G; Loening T; Andersson MK; Berg T; Lange A; Bankfalvi A; Samoilova V; Tiemann K; Buchwalow I
    Virchows Arch; 2015 Jan; 466(1):21-36. PubMed ID: 25344874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targets of vitamin D receptor signaling in the mammary gland.
    Welsh J
    J Bone Miner Res; 2007 Dec; 22 Suppl 2():V86-90. PubMed ID: 18290729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D regulation of HAS2, hyaluronan synthesis and metabolism in triple negative breast cancer cells.
    Narvaez CJ; Grebenc D; Balinth S; Welsh JE
    J Steroid Biochem Mol Biol; 2020 Jul; 201():105688. PubMed ID: 32360595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-proliferative action of vitamin D in MCF7 is still active after siRNA-VDR knock-down.
    Costa JL; Eijk PP; van de Wiel MA; ten Berge D; Schmitt F; Narvaez CJ; Welsh J; Ylstra B
    BMC Genomics; 2009 Oct; 10():499. PubMed ID: 19863778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A perspective on how the Vitamin D sterol/Vitamin D receptor (VDR) conformational ensemble model can potentially be used to understand the structure-function results of A-ring modified Vitamin D sterols.
    Mizwicki MT; Bula CM; Bishop JE; Norman AW
    J Steroid Biochem Mol Biol; 2005 Oct; 97(1-2):69-82. PubMed ID: 16055325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-6 Impairs the Activity of Vitamin D3 in the Regulation of Epithelial-Mesenchymal Transition in Triple Negative Breast Cancer.
    Abdel-Mohsen MA; Abo Deif SM; Abou-Shamaa LA
    Asian Pac J Cancer Prev; 2019 Aug; 20(8):2267-2273. PubMed ID: 31450894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of Sirt1-regulated FoxO protein function by the ligand-bound vitamin D receptor.
    An BS; Tavera-Mendoza LE; Dimitrov V; Wang X; Calderon MR; Wang HJ; White JH
    Mol Cell Biol; 2010 Oct; 30(20):4890-900. PubMed ID: 20733005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D receptor ligands, adenomatous polyposis coli, and the vitamin D receptor FokI polymorphism collectively modulate beta-catenin activity in colon cancer cells.
    Egan JB; Thompson PA; Vitanov MV; Bartik L; Jacobs ET; Haussler MR; Gerner EW; Jurutka PW
    Mol Carcinog; 2010 Apr; 49(4):337-52. PubMed ID: 20043299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.